Skip to content

Clinical trials

Phase 2 Dyspareunia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyspareunia Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20061
20071
20101
20131
20162
20182
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott3
Azure Biotech Inc.1
GTO Pharmaceutical, LLC1
Isifer AB1
Mayo Clinic1
ObsEva SA1
Ohio State University Comprehensive Cancer Center1
TherapeuticsMD1
Warner Chilcott1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyspareunia12
Dysmenorrhea6
Endometriosis6
Pelvic Pain6
Infertility3
Breast Carcinoma In Situ1
Breast Neoplasms1
Carcinoma, Intraductal, Noninfiltrating1
Sexual Dysfunctions, Psychological1
Vulvodynia1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.